Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 21Thoracic 9Breast 7Sarcoma 5Gynecologic 4Genitourinary 4Head & Neck 3Dermatologic 2CNS 2Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Brain Neoplasms 7Central Nervous System Neoplasms 6Breast Neoplasms 6Pancreatic Neoplasms 5Glioblastoma 5Ovarian Neoplasms 4Neoplasms 4Medulloblastoma 4Glioma 4Sarcoma 3Prostatic Neoplasms 3Osteosarcoma 3Melanoma 3Lung Neoplasms 3Colorectal Neoplasms 3Cholangiocarcinoma 3Carcinoma, Non-Small-Cell Lung 3Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 2Neuroectodermal Tumors, Primitive 2Neuroblastoma 2Neoplasms, Germ Cell and Embryonal 2Neoplasm Metastasis 2Multiple Myeloma 2Microphthalmia, Isolated, with Coloboma 5 2Lymphoma, Non-Hodgkin 2Head and Neck Neoplasms 2Esthesioneuroblastoma, Olfactory 2Diffuse Intrinsic Pontine Glioma 2

Interventions

Oxaliplatin 5Radiotherapy 3Leucovorin 3Irinotecan 3Erlotinib Hydrochloride 3Cetuximab 3Bevacizumab 3selpercatinib 2cediranib 2Trastuzumab 2Magnetic Resonance Spectroscopy 2Gemcitabine 2Fluorouracil 2Docetaxel 2ulixertinib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1trastuzumab biosimilar HLX02 1trametinib 1tipifarnib 1temsirolimus 1tanespimycin 1sargramostim 1sapanisertib 1relatlimab 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1oblimersen 1motexafin gadolinium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Colonic Neoplasms × Gemcitabine × CNS × Clear all
NCT04521686 2026-04-22

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Eli Lilly and Company

Phase 1 Active not recruiting
200 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcoma

Breast Neoplasms, Chondrosarcoma, Colonic Neoplasms, Glioblastoma, Glioma, Melanoma, Prostatic Neoplasms, Thyroid Neoplasms, Central Nervous System Neoplasms, Cholangiocarcinoma

NCT03607643 2018-07-31

A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

Leaf Vertical Inc.

Phase 1/2 Unknown
160 enrolled
CNSGastrointestinalPlasma cell

Colonic Neoplasms, Gallbladder Neoplasms, Glioblastoma, Liver Neoplasms, Multiple Myeloma, Pancreatic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡